Skip to main content
PMC home page
International Journal of Oral Science logoLink to International Journal of Oral Science
. 2020 Sep 30;12:28. doi: 10.1038/s41368-020-00096-z

Porphyromonas gingivalis disrupts vascular endothelial homeostasis in a TLR-NF-κB axis dependent manner

Mengru Xie 1,2,#, Qingming Tang 1,2,#, Shaoling Yu 1,2, Jiwei Sun 1,2, Feng Mei 1,2, Jiajia Zhao 1,2,✉, Lili Chen 1,2,✉
PMCID: PMC7527479  PMID: 32999278

Abstract

Cardiovascular disease is still the leading cause of mortality worldwide. Vascular endothelial dysfunction is viewed as the initial step of most cardiovascular diseases. Many studies have indicated that periodontal pathogens, especially Porphyromonas gingivalis, are closely correlated with vascular endothelial homeostasis, but the function of P. gingivalis and the underlying mechanisms are still elusive. To illuminate the effects and elucidate the mechanisms of P. gingivalis on endothelial structural integrity, we developed P. gingivalis infection models in vivo and in vitro. Endothelial cell proliferation, differentiation and apoptosis were detected. Here, we showed that P. gingivalis can impair endothelial integrity by inhibiting cell proliferation and inducing endothelial mesenchymal transformation and apoptosis of endothelial cells, which reduce the cell levels and cause the endothelium to lose its ability to repair itself. A mechanistic analysis showed that TLR antagonist or NF-κB signalling inhibitor can largely rescue the damaged integrity of the endothelium caused by P. gingivalis, suggesting that TLR-NF-κB signalling plays a vital role in vascular endothelial homeostasis destroyed by P. gingivalis. These results suggest a potential intervention method for the prevention and treatment of cardiovascular disease.

Subject terms: Bacterial pathogenesis, Mechanisms of disease

Introduction

Despite significant advances in the clinical treatment of cardiovascular disease, this condition is still the leading cause of death worldwide, highlighting an important yet unmet clinical need.1 The mechanisms involved in cardiovascular disease are complex. Recently, an increasing number of researchers have regarded inflammatory processes as central to the development and complications of cardiovascular disease.2–4 Accumulating evidence has shown that infections with certain microorganisms, such as Chlamydia pneumoniae,5,6 human immunodeficiency virus (HIV)7 and others,8–10 may be implicated in these processes. Recently, periodontal pathogens have attracted attention. These pathogens can gain access to the systemic circulation during common activities, such as brushing, flossing, and chewing, as well as during dental procedures,11 so they not only cause local inflammation and tissue destruction but also have systemic effects on organisms. Periodontal diseases caused by these pathogens show an epidemiological correlation with cardiovascular disease.12–14 Some researchers have already observed the existence of periodontal pathogens in lesions of the cardiovascular system.15–17 Moreover, in vivo studies have demonstrated an adverse association between periodontal pathogens and cardiovascular disease.18–20 In addition, periodontal therapy showed a reduction in systemic and aortic inflammation caused by periodontitis.21 These reports support the hypothesis that periodontal pathogen infection accounts for the pathogenesis of cardiovascular disease.

Porphyromonas gingivalis, a Gram-negative anaerobic bacterium, is a major periodontal pathogen. A recent study found that all patients with cardiovascular disease had P. gingivalis arterial colonization,15 suggesting an obvious link between P. gingivalis and cardiovascular disease. Animal studies have reported that oral infection with P. gingivalis accelerates atherosclerosis,19 and inoculation with P. gingivalis caused a significant increase in mortality due to cardiac rupture.22 It is known that P. gingivalis can frequently enter the vasculature. There are two possible ways. The gingival area of the periodontal region is surrounded by a multitude of lymph vessels with an open junction that can capture and trap bacteria.23 P. gingivalis can directly enter the vasculature via these lymph vessels. Lymph vessels can return extravasated fluid, proteins, and cells back into the circulation.24 In addition, this bacterium can enter the vasculature by trafficking by inflammatory cells from the local site of infection (such as the oral cavity). In this model, as a result of the tissue damage caused by the infection and subsequent inflammatory response, the inflammatory cells present at the local infection ingest the pathogens, and these pathogen-laden inflammatory cells move into the vasculature.25 In the vasculature, P. gingivalis can adhere to and invade vascular endothelial cells, whose normal functioning is crucial for maintaining vascular health and whose dysfunction is key in the initiation, progression and clinical complications of vascular disease.26 Endothelial cells stimulated with P. gingivalis produce high levels of proinflammatory cytokines, cell adhesion molecules, chemokines and nitric oxide,27,28 which have important effects on vascular function. These results indicate the association between P. gingivalis and endothelial function, strongly suggesting that P. gingivalis-induced endothelial dysfunction may be involved in the progression of cardiovascular disease. Nevertheless, it is compulsory to investigate the effects of P. gingivalis on endothelial biological properties and to elucidate the contribution of possible activation of signalling pathways.

Our results showed that P. gingivalis can inhibit the proliferation and induce endothelial mesenchymal transformation (EndMT) and apoptosis of endothelial cells by activating TLR-NF-κB signalling. P. gingivalis destroys vascular endothelial homeostasis by reducing its income and increasing expenditure, which provides a potential intervention method for the prevention and treatment of cardiovascular disease.

Results

P. gingivalis can severely damage vascular endothelial integrity

To examine the effects of P. gingivalis on vascular endothelial integrity, we used Balb/c mice as a model by tail-vein injection of P. gingivalis (107 CFU per mouse) once a week for 6 weeks. First, we measured the weight of the mice, and we found that there was no significant difference between the control and Pg (P. gingivalis) groups (Fig. 1a). Then, the mouse aorta was separated and stained with haematoxylin-eosin (H&E) for morphological detection and for the endothelial marker cluster of differentiation 31 (CD31) for endothelial integrity observation. In the control mice, the endothelium of the brachiocephalic artery (Fig. 1b) and aortic arch (Fig. 1c) were both intact. In the P. gingivalis-infected mice, the continuity of the endothelium was broken, showing that the anatomical integrity of the endothelium was damaged by P. gingivalis.

Fig. 1.

Fig. 1

Open in a new tab

P. gingivalis infection damages vascular endothelial integrity. a The weight of mice in the control and P. gingivalis (Pg) groups at 6, 7, 8, 9, 10, 11, and 12 weeks. Representative images after haematoxylin-eosin staining (H&E) and CD31 immunohistochemistry (IHC) of brachiocephalic artery (b) and aortic arch (c) tissue from the Balb/c mice with Pg tail-vein injection for 6 weeks (n = 5). Black arrow, the site where endothelial integrity was destroyed. Data were analysed using two-tailed unpaired t-tests (a) and are presented as the mean ± SD

P. gingivalis can obviously inhibit the proliferation of endothelial cells

The anatomical integrity of the endothelium is maintained by the balance of the sources and outlets of endothelial cells. The proliferation of endothelial cells is a key source of endothelium and is viewed as very important in the repair of areas denuded of endothelium as a result of injury.26 We first measured the proliferative ability of endothelial cells in vitro. Human umbilical endothelial cells (HUVECs) were treated with P. gingivalis at different multiplicities of infection (MOIs) for various periods of time. We observed a significant decrease in the viability of HUVECs at both higher MOIs (100 and 200) in the 48-h and 72-h groups (Fig. 2a). A low MOI (10) did not show these results (Fig. 2a). EdU assays and Ki67 staining were used to further detect the proliferation of HUVECs. The data showed that the number of proliferating cells was decreased significantly after P. gingivalis infection (MOI 100) for 48 h (Fig. 2b–e). In addition to HUVECs, we observed reduced proliferation of human aortic endothelial cells (HAECs) after P. gingivalis exposure (Fig. 2f, g). These data suggested that the decreased cell proliferation of endothelial cells is likely to be closely related to vascular endothelial injury.

Fig. 2.

Fig. 2

Open in a new tab

P. gingivalis inhibits proliferation and stimulates endothelial mesenchymal transformation (EndMT) in cultured endothelial cells. a The viability of human umbilical vein endothelial cells (HUVECs) treated with P. gingivalis (Pg) at different concentrations was measured by CCK-8 assays. MOI, multiplicity of infection. b EdU staining of HUVECs after Pg exposure for 48 h. Nuclei were stained with DAPI (blue). c The quantitative data of (b). d Immunofluorescence (IF) staining of Ki67 (green) in HUVECs with or without Pg infection for 48 h. e The quantitative data of (d). f EdU staining of human aortic endothelial cells (HAECs) after Pg exposure for 48 h. Nuclei were stained with DAPI (blue). g The quantitative data of (f). h HUVECs showed remarkable morphological changes after Pg treatment for 48 h. Representative images are presented. i Relative CD31, VE-cadherin (VE-cad), ACTA2 and FSP-1 mRNA levels were measured by real-time polymerase chain reaction (qRT-PCR) in the control or Pg-treated HUVECs. IF staining of CD31 (j) and α-SMA (k) in HUVECs after Pg infection or not. l Western blot analysis of the EndMT-related protein levels in the HUVECs after Pg exposure. m The quantitative data of l. n Western blot analysis of EndMT-related protein levels in HAECs after Pg exposure. o The quantitative data of (n). p Transwell assays were used to test the migration of the control and Pg-infected HUVECs. q The quantitative data of (p). Data were analysed using two-tailed unpaired t-tests (c, e, g, i, m, o, q) and are presented as the mean ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 compared to the control group

P. gingivalis induces endothelial mesenchymal transformation of endothelial cells

Endothelial mesenchymal transformation (EndMT) is a crucial step in endothelial cell differentiation to several lineages, and it has been demonstrated to be involved in many cardiovascular diseases.29 Due to EndMT, the endothelium can lose its integrity as a barrier in blood vessels.30 To test whether P. gingivalis could affect the EndMT process, we treated HUVECs with P. gingivalis for 48–72 h. P. gingivalis treatment led to striking morphological changes in HUVECs (Fig. 2h). The phenotype of endothelial cells was altered from a typical cobblestone-like to a fibroblast-like appearance, and the number of elongated and spindle-like HUVECs increased significantly (Fig. 2h). In accordance with the morphological change, the expression of the endothelial-specific markers CD31 and vascular endothelial cadherin (VE-cadherin) were reduced, and the mesenchymal markers fibroblast-specific protein (FSP-1) and α-smooth muscle actin (α-SMA) were increased in the P. gingivalis-treated HUVECs compared to the controls, both at the mRNA and protein levels (Fig. 2i–m). The relative protein level of vimentin (VIM), another EndMT marker, was also increased significantly (Fig. 2l, m). A similar change was also observed in HAECs (Fig. 2n, o). Except for the molecular changes, one of the characteristics of EndMT is that cells lose cell-cell adhesion and acquire an enhanced migratory phenotype. We performed a cell transwell assay to measure the migration of HUVECs. After incubation with P. gingivalis for 48 h, the number of migrated HUVECs was increased significantly, approximately 3.4-fold compared to that of the controls (Fig. 2p, q). Together, our findings indicated that P. gingivalis infection induced the differentiation of endothelial cells.

P. gingivalis triggers the apoptosis of endothelial cells

Endothelial cell apoptosis induced by risk factors is believed to lead to the denudation or dysfunction of the intact endothelial monolayer.31 To explore the reason for the loss of endothelial integrity, we next measured the apoptosis of endothelial cells. TUNEL staining of the brachiocephalic artery showed that after P. gingivalis infection, the number of apoptotic endothelial cells was increased (Fig. 3a). We then treated HUVECs with P. gingivalis at different concentrations for 24 h and found that the ratio of apoptotic cells was obviously elevated after P. gingivalis infection, from ~5% (control) to ~7.5% (MOI 100) and ~11% (MOI 200) (Fig. 3b, c). The expression of the proapoptotic proteins cleaved Caspase 3 (CAS-CL) and BAX was increased, and the expression of the antiapoptotic proteins Caspase 3 and BCL2 was decreased not only in the P. gingivalis-infected HUVECs (Fig. 3d, e) but also in the P. gingivalis-infected HAECs (Fig. 3f, g). Collectively, these observations demonstrated that P. gingivalis-destroyed vascular endothelial homeostasis mainly by inhibiting the proliferation and inducing EndMT and apoptosis of endothelial cells.

Fig. 3.

Fig. 3

Open in a new tab

P. gingivalis triggers endothelial apoptosis. a Apoptosis in vivo was assessed by TUNEL staining in brachiocephalic artery tissue from the Balb/c mice treated with or without P. gingivalis (Pg) (n = 5). b Apoptosis was evaluated by flow cytometry of human umbilical vein endothelial cells (HUVECs) treated with Pg for 24 h. c The quantitative data of (b). d Western blot analysis of the indicated protein levels in HUVECs after Pg stimulation for 24 h. e The quantitative data of (d). f Western blot analysis of the indicated protein levels in human aortic endothelial cells (HAECs) after Pg stimulation for 24 h. g The quantitative data of (f). Data were analysed using a one-way ANOVA (c) or two-tailed unpaired t-tests (e, g) and are presented as the mean ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 compared to the control group

P. gingivalis destroys vascular endothelial homeostasis by combining with membranous TLRs

Toll-like receptors (TLRs) are thought to mediate P. gingivalis recognition and in turn activate downstream signalling pathways to regulate host cell responses.32 Similarly, we detected activated TLR downstream signalling in HUVECs after P. gingivalis infection (Fig. 4a, b). To further evaluate whether TLRs participated in P. gingivalis-induced vascular endothelial damage, the TLR signalling antagonist OxPAPC was used. OxPAPC inhibited P. gingivalis-activated TLR signalling in a dose-dependent manner (Fig. 4c–e), and the effects of P. gingivalis on proliferation, EndMT and apoptosis of HUVECs were also reversed (Fig. 4f–n). The CCK-8 assay showed that the viability of HUVECs was almost completely recovered when OxPAPC was added (Fig. 4f). Consistently, the ratio of EdU-positive cells was increased to the comparable level of control cells when OxPAPC was used (Fig. 4g, h). Next, we examined the change in morphology, the expression of EndMT markers and the migration of HUVECs with OxPAPC treatment. As shown, P. gingivalis led to striking morphological changes in HUVECs, but these changes were attenuated by OxPAPC (Fig. 4i). Additionally, the downregulated expression of CD31 and VE-cadherin and the upregulated expression of α-SMA, VIM and FSP-1 were reversed by OxPAPC (Fig. 4j). In addition, the transwell assay showed that the enhanced migration of P. gingivalis-treated HUVECs was alleviated almost to the same level of control cells by OxPAPC treatment (Fig. 4k, l), indicating that blockade of the TLR signalling pathway reversed the process of EndMT. In addition, we detected a decrease in apoptosis in the OxPAPC-treated HUVECs. The ratio of apoptotic cells was elevated after P. gingivalis infection, and it was reduced after treatment with OxPAPC (Fig. 4m, n). Together, our results revealed that TLRs account for the P. gingivalis-mediated impairment of the integrity of the endothelium.

Fig. 4.

Fig. 4

Open in a new tab

P. gingivalis damages the integrity of endothelial cells through TLRs. a Western blot analysis of TLR signalling-related protein levels in human umbilical vein endothelial cells (HUVECs) after P. gingivalis (Pg) exposure for 2 h or 24 h. b The quantitative data of (a). c Confocal images of IRAK1 expression in HUVECs treated with Pg and/or the TLR antagonist OxPAPC (30 μg·mL−1) for 2 h. d Western blot analysis of the p-IRAK1, IRAK1, and IRAK4 protein levels in the HUVECs treated with Pg and/or OxPAPC (10, 20, 30 μg·mL−1) for 2 h. e The quantitative data of (d). f The viability of HUVECs treated with Pg and/or OxPAPC at different timepoints was measured by CCK-8 assays. g EdU staining of HUVECs treated with Pg and/or OxPAPC (30 μg·mL−1) for 48 h. Nuclei were stained with DAPI (blue). h The quantitative data of (g). i HUVECs showed remarkable morphological changes after Pg and/or OxPAPC treatment for 48 h. Representative images are presented. j Western blot analysis of the EndMT-related protein levels in the HUVECs treated with Pg and/or OxPAPC (10, 20, 30 μg·mL−1) for 72 h. k Transwell assays were used to test the migration of HUVECs treated with Pg and/or OxPAPC (30 μg·mL−1) for 48 h. l The quantitative data of (k). m Apoptosis was evaluated by flow cytometry of the HUVECs treated with Pg and/or OxPAPC (30 μg·mL−1) for 24 h. n The quantitative data of (m). Data were analysed using a two-tailed unpaired t-test (b) or one-way ANOVA (e, h, l, n) or a two-way ANOVA (f) and are presented as the mean ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 compared to the control group. ns = not significant. #P < 0.05; ##P < 0.01; ###P < 0.001 compared to the Pg group

NF-κB signalling plays a critical role in P. gingivalis-destroyed endothelial homeostasis

Considering that TLRs regulate cell function mostly by triggering many other downstream signalling pathways33 and NF-κB is the common pathway that is also tightly associated with cardiovascular diseases,34 we proposed to further explore the link between NF-κB signalling and P. gingivalis-induced endothelial damage. BAY 11-7082, an NF-κB inhibitor, was employed. As shown in Fig. 5a, b, NF-κB signalling was activated upon P. gingivalis exposure. BAY 11-7082 significantly inhibited this pathway (Fig. 5c–e). Notably, we observed that BAY 11-7082 recovered half of the proliferative ability of HUVECs reduced by P. gingivalis (Fig. 5f, g) and attenuated approximately 60% of the migration and apoptosis of HUVECs induced by P. gingivalis (Fig. 5h–k). These results indicated that blockade of NF-κB signalling rescued the effects of P. gingivalis infection in HUVECs by at least half, suggesting that NF-κB signalling plays a critical role in the progression of P. gingivalis-destroyed endothelial homeostasis.

Fig. 5.

Fig. 5

Open in a new tab

NF-kappaB signalling plays a critical role in P. gingivalis-destroyed endothelial homeostasis. a Western blot analysis of NF-kappaB (NF-κB) signalling-related protein levels in human umbilical vein endothelial cells (HUVECs) after P. gingivalis (Pg) exposure for 2 h. b The quantitative data of (a). c Confocal images of p65 expression in the HUVECs treated with Pg and/or NF-κB inhibitor BAY 11-7082 (BAY, 1 μmol·L−1) for 2 h. d Western blot analysis of p-p65, p65, and IκBα protein levels in the HUVECs treated with Pg and/or BAY (0.1, 0.5, 1 μmol·L−1) for 2 h. e The quantitative data of (d). f EdU staining of the HUVECs treated with Pg and/or BAY (1 μmol·L−1) for 48 h. Nuclei were stained with DAPI (blue). g The quantitative data of (f). h Transwell assays were used to test the migration of HUVECs treated with Pg and/or BAY (1 μmol·L−1) for 48 h. i The quantitative data of (h). j Apoptosis was evaluated by flow cytometry of the HUVECs treated with Pg and/or BAY (1 μmol·L−1) for 24 h. k The quantitative data of (j). Data were analysed using a two-tailed unpaired t-test (b) or one-way ANOVA (e, g, i, k) and are presented as the means ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 compared to the control group. ns = not significant. #P < 0.05; ##P < 0.01; ###P < 0.001 compared to the Pg group

Discussion

The vascular endothelium is a single cell layer that lines the entire circulatory system and is viewed as the first line of defence against cardiovascular disease. This structure is an interface between the bloodstream and the vessel wall. The endothelium can respond to several types of stimuli and regulate platelet function, inflammatory responses, and vascular smooth muscle cell growth and migration, in addition to modulating vascular tone by synthesizing and releasing vasoactive substances.26 The integrity of the endothelium plays a key role in maintaining its physiological function. Endothelial injury is believed to be of primary importance in the pathogenesis of vascular disease. When suffering prolonged and/or repeated exposure, endothelial cell protective activation is exhausted, thus leading to endothelial dysfunction, detachment and fragmentation into microparticles; consequently, the integrity is disrupted. The stimuli include high levels of lipoprotein,35 proinflammatory cytokines such as TNFα and IL-6 (ref. 36) and foreign pathogen infections such as viruses37 in the bloodstream. In our study, we found that a periodontal pathogen, P. gingivalis, is also such a stimulus. After exposure to P. gingivalis, we observed the loss of endothelial integrity in vivo.

The interaction between P. gingivalis and endothelial integrity has been studied for several years. It is well established that P. gingivalis has a direct route to the circulatory system by transient bacteraemia (the presence of bacteria in the blood) and that these events occur commonly and frequently.38,39 It has also been reported that P. gingivalis is highly invasive in several cell types, including endothelial cells.40,41 Studies have shown that P. gingivalis can adhere to and invade endothelial cells and stimulate the expression of proinflammatory cytokines, such as IL-6, IL-8 and MCP-1, and induce enhanced endothelial cell surface expression of VCAM-1, ICAM-1 and E-selectin27 which increases mononuclear cell adhesion and promotes vascular inflammation. P. gingivalis can also induce iNOS, inhibit eNOS expression and regulate the release of NO without any additional stimulant in endothelial cells,28 contributing to nitrative stress and endothelial function impairment. These studies all indicate that P. gingivalis can damage endothelial integrity, but they only focus on functional or biosynthetic aspects. The structural change of endothelial cells by P. gingivalis require further studies. Our data demonstrated that infection with P. gingivalis leads to increased apoptosis and EndMT of endothelial cells, damaging endothelial integrity. However, endothelial integrity depends not only on the extent of injury but also on the appropriate availability of functional endothelial cells. Notably, we detected a reduced proliferative ability of P. gingivalis-stimulated endothelial cells. These findings demonstrate that P. gingivalis not only impairs endothelial integrity but also inhibits its repair ability.

TLRs are a group of pathogen-associated molecular pattern (PAMP) recognition receptors that play an important role in innate immune signalling in response to microbial infection. It has been suggested that TLR signalling may be activated and that TLR expression may be altered in cardiovascular disease.42,43 Specific TLRs have demonstrated functional pattern recognition of peptidoglycan and bacterial lipopeptides (TLR2), double-stranded RNA (TLR3), lipopolysaccharide (LPS; TLR4), flagellin (TLR5), and unmethylated CpG DNA motifs (TLR9).44 Among these TLRs, TLR2 and TLR4 are the most common TLRs in the host response to P. gingivalis lipopolysaccharides45 and fimbriae.46 Previous studies have demonstrated that P. gingivalis can colocalize with TLR2 and manipulate TLR2 downstream signalling to uncouple bacterial clearance from inflammation and promote dysbiosis.32 P. gingivalis also invades HAECs by TLR4.47 Consistent with these studies, we also found that TLR signalling was activated after P. gingivalis was added, and the effects of P. gingivalis on HUVECs were reversed almost completely when TLR signalling was inhibited. TLRs frequently coexist with NF-κB, which induces the expression of TLRs and regulates the downstream signalling of TLRs on ligand engagement.48–50 In the present study, we detected the activation of NF-κB signalling in P. gingivalis-infected HUVECs. After addition of the inhibitor BAY 11-7082, the effects of P. gingivalis were attenuated by ~60%, suggesting that the remaining effects (~40%) might come from other downstream mechanisms of TLRs, which need further research.

Our data confirmed the critical role of TLR-NF-κB signalling in the progression of P. gingivalis-destroyed endothelial homeostasis and suggest that specific inhibition of TLR-NF-κB activation by P. gingivalis concomitantly reduces the risk of infection-accelerated cardiovascular disease. This strategy may slow the progression of cardiovascular disease by regulating possible therapeutic targets.

Cardiovascular disease is a multifactorial disease, and the reason why it can cause endothelial dysfunction is also complex. Here, by using P. gingivalis via the bloodstream for assessment of destroyed endothelium, we demonstrated an experimental link between P. gingivalis and endothelial homeostasis, which also suggests the negative impact of periodontal pathogens on cardiovascular disease. In addition, studies have shown that periodontal treatment can result in a reduction in systemic inflammation and endothelial dysfunction,51 which further confirms the importance of periodontal intervention in preventing or treating cardiovascular disease. Although there is no overwhelming evidence that periodontal therapy can prevent cardiovascular disease or modify its outcomes, according to the results of our study, it is still necessary for oral clinicians to remind patients to pay attention to periodontal health.

Materials and methods

Bacterial culture

P. gingivalis W83 was kindly provided by the West China College of Stomatology, Sichuan University, China. P. gingivalis was grown on anaerobic blood agar plates in a chamber with 85% N2, 5% H2, and 10% CO2 at 37 °C for 5–7 days. It was then inoculated into a liquid broth of brain heart infusion (BHI) supplemented with hemin (5 µg·mL−1) and vitamin K (5 µg·mL−1) for over 24 h in the same chamber.

Mice

Ten male Balb/c mice of 6 weeks of age were used in this study. Mice were randomly divided into two groups (n = 5 per group): (1) control group, mice administered 0.1 mL of PBS via tail-vein injection once a week; (2) Pg group, mice with P. gingivalis (107 CFU in 0.1 mL PBS) administered via tail-vein injection once a week. All mice were kept in a standard environment with controlled temperature and humidity under specific-pathogen-free conditions within individually ventilated cages with food and water ad libitum. After 6 weeks, the mice were euthanized at the same time, and the tissues were collected. The thoracic abdominal aorta and brachiocephalic artery were fixed in 4% paraformaldehyde (PFA) for further detection. There were no observable behavioural changes in the mice injected with P. gingivalis or PBS throughout the study. All animal experiments were carried out with the consent of the Institutional Animal Care and Use Committee of Tongji Medical College (Wuhan, China).

Immunostaining and immunohistochemistry

For the morphological detection of aortas, haematoxylin-eosin staining (H&E) was implemented following routine procedures. Briefly, after deparaffinization and rehydration, sections were stained with haematoxylin solution for 5 min, followed by incubation with acidic ethanol and rinsing in distilled water. The sections were stained with eosin solution for 3 min followed by dehydration and clearing. Morphological features of the indicated specimens were observed under optical microscopy.

For the detection of apoptosis, a TUNEL assay was performed. Tissue sections of brachiocephalic arteries from the sacrificed mice were incubated in xylene and rehydrated in decreasing concentrations of alcohol, after which the sections were treated with 3% EDTA at a pH of 7.2 for 1 h. Endogenous peroxidase activity was inactivated by 3% H2O2. The TUNEL assay was then performed using an in situ Apoptosis Detection Kit (TaKaRa), following instructions from the manufacturer.

For immunohistochemistry analysis, mouse paraffin-embedded aortic tissue sections were incubated with primary antibody (CD31 (Abcam)) overnight at 4 °C. Then, the sections were washed and incubated with secondary antibody conjugated with horseradish peroxidase for 1 h at room temperature. The expression of the various molecules was visualized using DAB substrate, which reacts with horseradish peroxidase to yield a brown coloured product on the tissue sections.

Cell culture and reagents

Human umbilical vein endothelial cells (HUVECs; ScienCell) and human aortic endothelial cells (HAECs; ScienCell) were cultured in endothelial cell medium (ScienCell) supplemented with 5% foetal bovine serum and 1% endothelial cell growth factors. Cells were maintained at 37 °C in a humidified atmosphere of 5% CO2 in air. The passage of cells was usually 4 to 6. OxPAPC (Invitrogen) and BAY11–7082 (MedChemExpress) were used as inhibitors.

Quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR)

Total RNA from HUVECs was isolated by TRIzol reagent (TaKaRa). Reverse transcription was performed using a Superscript II-reverse transcriptase kit (Vazyme). qRT-PCR was performed using Subsequent Fast SYBR Green qPCR on Step One Plus real-time PCR systems (Applied Biosystems) according to the manufacturer’s instructions. The sequences of the primers used for qRT-PCR are described in Table 1. Quantification of target gene expression was calculated relative to the reference glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene. The mean minimal cycle threshold values (Ct) were calculated from triplicate reactions.

Table 1.

Primers for quantitative reverse transcription-polymerase chain reaction (qRT-PCR)

Genes Forward primer 5′–3′ Reverse primer 5′–3′
ACTA2 TGAGCGTGGCTATTCCTTCGTT GCCCATCAGGCAACTCGTAACT
CD31 AACAGTGTTGACATGAAGAGCC TGTAAAACAGCACGTCATCCTT
FSP-1 GCTCAACAAGTCAGAACTAAAGGAG GCAGCTTCATCTGTCCTTTTC
VE-cad TTGGAACCAGATGCACATTGAT TCTTGCGACTCACGCTTGAC
GAPDH GGAGCGAGATCCCTCCAAAAT GGCTGTTGTCATACTTCTCATGG
Open in a new tab

Western blot analysis

Total cellular proteins were extracted using RIPA buffer with fresh protease inhibitors (InvivoGen) and phosphatase inhibitors (InvivoGen). The concentration of proteins was quantified using the BCA kit (Beyotime). The proteins were separated by electrophoresis on a 10% SDS-PAGE gel and then transferred onto a PVDF membrane. After blocking for 1 h with skim milk, the membranes were incubated with primary antibodies against ACTA2 (Proteintech), BAX (Proteintech), BCL2 (Proteintech), Caspase 3 (Cell Signaling Technology), CD31 (Abcam), FSP-1 (Proteintech), VE-cadherin (Proteintech), Vimentin (Proteintech) and GAPDH (Proteintech) overnight at 4 °C. Then, the cells were incubated with secondary antibodies for more than 1 h. The protein-antibody complexes were then visualized using the enhanced chemiluminescence detection system. Quantification of the protein expression level was calculated using ImageJ software.

Apoptosis analysis

In HUVECs, apoptosis induced by P. gingivalis was detected quantitatively with an Annexin-V-fluorescein isothiocyanate (FITC) apoptosis detection kit (InvivoGen). Briefly, cells were collected and washed with cold PBS. Then, they were incubated and stained with FITC-Annexin V at room temperature in the dark for 15 min followed by PI addition. The cells were analysed by a BD FACS Canto ІІ Flow Cytometer. Data are expressed as the mean of total apoptosis, representing the sum of early and late apoptosis.

Morphological evaluation

HUVECs were seeded into 6-well plates at a proper density, after which infection of P. gingivalis was carried out. Incubation of P. gingivalis with HUVECs was performed for 48 h. Cells were washed with PBS three times and fixed with 4% PFA. Morphological changes were then analysed using a microscope.

Immunofluorescence staining

Cells were fixed with 4% paraformaldehyde for 10 min, washed three times with PBS, and treated with 0.1% Triton X-100 for 10 min. Next, primary antibodies against CD31 (Abcam), ACTA2 (Proteintech) and Ki67 (Abcam) were applied and incubated overnight at 4 °C in a humidified chamber. After extensive rinsing with PBS, the coverslips were incubated with secondary antibody (488-labelled goat anti-rabbit antibody, Proteintech) for 2 h at room temperature. After three washes with PBS, cell nuclei were counterstained with DAPI. Immunofluorescence photographs were taken by a fluorescent confocal microscope (Nikon A1-Si) with NIS software for acquisition.

Cell migration assay

The migration assay was performed using a modified Boyden chamber apparatus (Transwell apparatus, 8.0-μm pore size, Corning). An appropriate number of HUVECs was seeded into the upper chamber with serum-free culture medium, and complete medium was added to the lower chambers of the inserts in 24-well plates. After infection with P. gingivalis at 37 °C for 48 h, HUVECs were fixed in 4% paraformaldehyde and stained with 1% crystal violet. Nonmigrated HUVECs were removed from the upper face of the Transwell membrane with a cotton swab. The migrated cells were manually calculated in five random microscopic fields using a microscope.

Cell viability

Cell Counting Kit-8 (CCK-8) (Beyotime) was used to measure cell viability. HUVECs were seeded in 96-well plates at a density of 2 × 103 cells per well. Cells were exposed to P. gingivalis with or without inhibitor pretreatment. After the indicated times, the cells were incubated with 10 μl CCK-8 solution at 37 °C for 1 h following the manufacturer’s instructions. Optical density (OD) values at 450 nm were obtained using a microplate reader.

EdU staining

HUVECs and HAECs were seeded in 12-well plates at a degree of fusion of 50% cells per well. Cells were exposed to P. gingivalis with or without inhibitor pretreatment. After 48 h, EdU staining was chosen for direct observation of cell proliferation. Experimental procedures were performed according to the manufacturer’s protocols (Beyotime). Briefly, click working solution was mixed following the instructions. Cell samples were then incubated with working solution for 30 min at room temperature without light. Hoechst was selected for nuclear staining. Washing buffer was used to clean the residual solution. Immunofluorescence images were obtained by fluorescence microscopy. The proportions of cells showing EdU labelling were quantified using the ImageJ programme.

Statistical analysis

Statistical significance was assessed using Student’s t-test or analysis of variance (ANOVA). The results are presented as the mean ± standard deviation (SD). A p value < 0.05 was considered statistically significant, and all statistical analyses were performed with GraphPad Prism 7.0 software.

Acknowledgements

This work was supported by the National Science Foundation for Distinguished Young Scholars of China (31725011 to Lili Chen) and Young Scientists of China (81800986 to Qingming Tang) and the Chinese Stomatological Association (CSA-Z2015-01 to Lili Chen).

Author contributions

L.C. and J.Z. conceived, designed and supervised the study and guided the interpretation of the results and the preparation of the paper. M.X. and Q.T. managed the daily experiments. S.Y. and J.S. assisted with experimental work. F.M. helped to interpreted the data. M.X., Q.T. and L.C. edited the paper with input from all authors.

Competing interests

The authors declare no competing interests.

Footnotes

These authors contributed equally: Mengru Xie, Qingming Tang

Contributor Information

Jiajia Zhao, Email: zhaojiajia0130@163.com.

Lili Chen, Email: chenlili1030@hust.edu.cn.

References

  • 1.Epelman S, Liu PP, Mann DL. Role of innate and adaptive immune mechanisms in cardiac injury and repair. Nat. Rev. Immunol. 2015;15:117–129. doi: 10.1038/nri3800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ruparelia N, Chai JT, Fisher EA, Choudhury RP. Inflammatory processes in cardiovascular disease: a route to targeted therapies. Nat. Rev. Cardiol. 2017;14:133–144. doi: 10.1038/nrcardio.2016.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 2005;352:1685–1695. doi: 10.1056/NEJMra043430. [DOI] [PubMed] [Google Scholar]
  • 4.Frangogiannis NG. Regulation of the inflammatory response in cardiac repair. Circ. Res. 2012;110:159–173. doi: 10.1161/CIRCRESAHA.111.243162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Vink A, et al. Distribution of Chlamydia pneumoniae in the human arterial system and its relation to the local amount of atherosclerosis within the individual. Circulation. 2001;103:1613–1617. doi: 10.1161/01.CIR.103.12.1613. [DOI] [PubMed] [Google Scholar]
  • 6.Chen S, et al. Chlamydia and lipids engage a common signaling pathway that promotes atherogenesis. J. Am. Coll. Cardiol. 2018;71:1553–1570. doi: 10.1016/j.jacc.2018.01.072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Shah ASV, et al. Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis. Circulation. 2018;138:1100–1112. doi: 10.1161/CIRCULATIONAHA.117.033369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Fournier PE, et al. Coxiella burnetii infection of aneurysms or vascular grafts: report of seven cases and review. Clin. Infect. Dis. 1998;26:116–121. doi: 10.1086/516255. [DOI] [PubMed] [Google Scholar]
  • 9.Natanson C, et al. Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. J. Clin. Invest. 1989;83:243–251. doi: 10.1172/JCI113866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Freitas-Ferraz AB, et al. Contemporary epidemiology and outcomes in recurrent infective endocarditis. Heart. 2020;106:596–602. doi: 10.1136/heartjnl-2019-315433. [DOI] [PubMed] [Google Scholar]
  • 11.Forner L, Larsen T, Kilian M, Holmstrup P. Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. J. Clin. Periodontol. 2006;33:401–407. doi: 10.1111/j.1600-051X.2006.00924.x. [DOI] [PubMed] [Google Scholar]
  • 12.Czesnikiewicz-Guzik M, et al. Causal association between periodontitis and hypertension: evidence from Mendelian randomization and a randomized controlled trial of non-surgical periodontal therapy. Eur. Heart J. 2019;40:3459–3470. doi: 10.1093/eurheartj/ehz646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ryden L, et al. Periodontitis increases the risk of a first myocardial infarction: a report from the PAROKRANK study. Circulation. 2016;133:576–583. doi: 10.1161/CIRCULATIONAHA.115.020324. [DOI] [PubMed] [Google Scholar]
  • 14.Vedin O, et al. Periodontal disease in patients with chronic coronary heart disease: prevalence and association with cardiovascular risk factors. Eur. J. Prev. Cardiol. 2015;22:771–778. doi: 10.1177/2047487314530660. [DOI] [PubMed] [Google Scholar]
  • 15.Mougeot JC, et al. Porphyromonas gingivalis is the most abundant species detected in coronary and femoral arteries. J. Oral. Microbiol. 2017;9:1281562. doi: 10.1080/20002297.2017.1281562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Lanter BB, Sauer K, Davies DG. Bacteria present in carotid arterial plaques are found as biofilm deposits which may contribute to enhanced risk of plaque rupture. mBio. 2014;5:e01206–e01214. doi: 10.1128/mBio.01206-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Pessi T, et al. Bacterial signatures in thrombus aspirates of patients with myocardial infarction. Circulation. 2013;127:1219–1228. doi: 10.1161/CIRCULATIONAHA.112.001254. [DOI] [PubMed] [Google Scholar]
  • 18.Hyvarinen K, et al. A common periodontal pathogen has an adverse association with both acute and stable coronary artery disease. Atherosclerosis. 2012;223:478–484. doi: 10.1016/j.atherosclerosis.2012.05.021. [DOI] [PubMed] [Google Scholar]
  • 19.Li L, Messas E, Batista EL, Jr, Levine RA, Amar S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation. 2002;105:861–867. doi: 10.1161/hc0702.104178. [DOI] [PubMed] [Google Scholar]
  • 20.Kesavalu L, et al. Increased atherogenesis during Streptococcus mutans infection in ApoE-null mice. J. Dent. Res. 2012;91:255–260. doi: 10.1177/0022034511435101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Cui D, Li H, Lei L, Chen C, Yan F. Nonsurgical periodontal treatment reduced aortic inflammation in ApoE(-/-) mice with periodontitis. Springerplus. 2016;5:940. doi: 10.1186/s40064-016-2637-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Shiheido Y, et al. Porphyromonas gingivalis, a periodontal pathogen, enhances myocardial vulnerability, thereby promoting post-infarct cardiac rupture. J. Mol. Cell. Cardiol. 2016;99:123–137. doi: 10.1016/j.yjmcc.2016.03.017. [DOI] [PubMed] [Google Scholar]
  • 23.Iwai T. Periodontal bacteremia and various vascular diseases. J. Periodontal Res. 2009;44:689–694. doi: 10.1111/j.1600-0765.2008.01165.x. [DOI] [PubMed] [Google Scholar]
  • 24.Berggreen E, Wiig H. Lymphangiogenesis and lymphatic function in periodontal disease. J. Dent. Res. 2013;92:1074–1080. doi: 10.1177/0022034513504589. [DOI] [PubMed] [Google Scholar]
  • 25.Gibson FC, 3rd, Yumoto H, Takahashi Y, Chou HH, Genco CA. Innate immune signaling and Porphyromonas gingivalis-accelerated atherosclerosis. J. Dent. Res. 2006;85:106–121. doi: 10.1177/154405910608500202. [DOI] [PubMed] [Google Scholar]
  • 26.Cahill PA, Redmond EM. Vascular endothelium - gatekeeper of vessel health. Atherosclerosis. 2016;248:97–109. doi: 10.1016/j.atherosclerosis.2016.03.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Roth GA, et al. Infection with a periodontal pathogen increases mononuclear cell adhesion to human aortic endothelial cells. Atherosclerosis. 2007;190:271–281. doi: 10.1016/j.atherosclerosis.2006.03.018. [DOI] [PubMed] [Google Scholar]
  • 28.Sun W, et al. Porphyromonas gingivalis stimulates the release of nitric oxide by inducing expression of inducible nitric oxide synthases and inhibiting endothelial nitric oxide synthases. J. Periodontal Res. 2010;45:381–388. doi: 10.1111/j.1600-0765.2009.01249.x. [DOI] [PubMed] [Google Scholar]
  • 29.Kovacic JC, et al. Endothelial to mesenchymal transition in cardiovascular disease: JACC state-of-the-art review. J. Am. Coll. Cardiol. 2019;73:190–209. doi: 10.1016/j.jacc.2018.09.089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Good RB, et al. Endothelial to mesenchymal transition contributes to endothelial dysfunction in pulmonary arterial hypertension. Am. J. Pathol. 2015;185:1850–1858. doi: 10.1016/j.ajpath.2015.03.019. [DOI] [PubMed] [Google Scholar]
  • 31.Dardik A, et al. Differential effects of orbital and laminar shear stress on endothelial cells. J. Vasc. Surg. 2005;41:869–880. doi: 10.1016/j.jvs.2005.01.020. [DOI] [PubMed] [Google Scholar]
  • 32.Maekawa T, et al. Porphyromonas gingivalis manipulates complement and TLR signaling to uncouple bacterial clearance from inflammation and promote dysbiosis. Cell Host Microbe. 2014;15:768–778. doi: 10.1016/j.chom.2014.05.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Brown J, Wang H, Hajishengallis GN, Martin M. TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk. J. Dent. Res. 2011;90:417–427. doi: 10.1177/0022034510381264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Fiordelisi A, Iaccarino G, Morisco C, Coscioni E, Sorriento D. NFkappaB is a key player in the crosstalk between inflammation and cardiovascular diseases. Int. J. Mol. Sci. 2019;20:1599. doi: 10.3390/ijms20071599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Pirro M, et al. Lipoprotein(a) and inflammation: a dangerous duet leading to endothelial loss of integrity. Pharmacol. Res. 2017;119:178–187. doi: 10.1016/j.phrs.2017.02.001. [DOI] [PubMed] [Google Scholar]
  • 36.Rochfort KD, Collins LE, McLoughlin A, Cummins PM. Tumour necrosis factor-alpha-mediated disruption of cerebrovascular endothelial barrier integrity in vitro involves the production of proinflammatory interleukin-6. J. Neurochem. 2016;136:564–572. doi: 10.1111/jnc.13408. [DOI] [PubMed] [Google Scholar]
  • 37.Modhiran N, et al. Dengue virus NS1 protein activates cells via toll-like receptor 4 and disrupts endothelial cell monolayer integrity. Sci. Transl. Med. 2015;7:304ra142. doi: 10.1126/scitranslmed.aaa3863. [DOI] [PubMed] [Google Scholar]
  • 38.Carroll GC, Sebor RJ. Dental flossing and its relationship to transient bacteremia. J. Periodontol. 1980;51:691–692. doi: 10.1902/jop.1980.51.12.691. [DOI] [PubMed] [Google Scholar]
  • 39.Silver JG, Martin AW, McBride BC. Experimental transient bacteraemias in human subjects with varying degrees of plaque accumulation and gingival inflammation. J. Clin. Periodontol. 1977;4:92–99. doi: 10.1111/j.1600-051X.1977.tb01888.x. [DOI] [PubMed] [Google Scholar]
  • 40.Lamont RJ, et al. Porphyromonas gingivalis invasion of gingival epithelial cells. Infect. Immun. 1995;63:3878–3885. doi: 10.1128/IAI.63.10.3878-3885.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Deshpande RG, Khan MB, Genco CA. Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis. Infect. Immun. 1998;66:5337–5343. doi: 10.1128/IAI.66.11.5337-5343.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation. 2002;105:1158–1161. doi: 10.1161/circ.105.10.1158. [DOI] [PubMed] [Google Scholar]
  • 43.Naiki Y, et al. TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis. J. Immunol. 2008;181:7176–7185. doi: 10.4049/jimmunol.181.10.7176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Imler JL, Hoffmann JA. Toll signaling: the TIReless quest for specificity. Nat. Immunol. 2003;4:105–106. doi: 10.1038/ni0203-105. [DOI] [PubMed] [Google Scholar]
  • 45.Bainbridge BW, Darveau RP. Porphyromonas gingivalis lipopolysaccharide: an unusual pattern recognition receptor ligand for the innate host defense system. Acta Odontol. Scand. 2001;59:131–138. doi: 10.1080/000163501750266710. [DOI] [PubMed] [Google Scholar]
  • 46.Asai Y, Ohyama Y, Gen K, Ogawa T. Bacterial fimbriae and their peptides activate human gingival epithelial cells through toll-like receptor 2. Infect. Immun. 2001;69:7387–7395. doi: 10.1128/IAI.69.12.7387-7395.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Yumoto H, et al. Sensitization of human aortic endothelial cells to lipopolysaccharide via regulation of toll-like receptor 4 by bacterial fimbria-dependent invasion. Infect. Immun. 2005;73:8050–8059. doi: 10.1128/IAI.73.12.8050-8059.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Suganami T, et al. Role of the toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler. Thromb. Vasc. Biol. 2007;27:84–91. doi: 10.1161/01.ATV.0000251608.09329.9a. [DOI] [PubMed] [Google Scholar]
  • 49.Hu ZP, et al. Melatonin ameliorates vascular endothelial dysfunction, inflammation, and atherosclerosis by suppressing the TLR4/NF-kappaB system in high-fat-fed rabbits. J. Pineal Res. 2013;55:388–398. doi: 10.1111/jpi.12085. [DOI] [PubMed] [Google Scholar]
  • 50.Yang L, et al. Overexpression of CRY1 protects against the development of atherosclerosis via the TLR/NF-kappaB pathway. Int. Immunopharmacol. 2015;28:525–530. doi: 10.1016/j.intimp.2015.07.001. [DOI] [PubMed] [Google Scholar]
  • 51.Lockhart PB, et al. Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation. 2012;125:2520–2544. doi: 10.1161/CIR.0b013e31825719f3. [DOI] [PubMed] [Google Scholar]

Articles from International Journal of Oral Science are provided here courtesy of Nature Publishing Group

RESOURCES